Open Access
circDCUN1D4 suppresses tumor metastasis and glycolysis in lung adenocarcinoma by stabilizing TXNIP expression
Publication type: Journal Article
Publication date: 2021-03-01
scimago Q1
wos Q1
SJR: 2.046
CiteScore: 12.9
Impact factor: 6.1
ISSN: 21622531
PubMed ID:
33425493
Drug Discovery
Molecular Medicine
Abstract
Aberrant expression of circular RNAs (circRNAs) is involved in cancer progression through interaction with RNA-binding proteins (RBPs). Herein, we screened circRNA expression of A549 cells in circBase and the crosslinking immunoprecipitation (CLIP) data of human antigen R (HuR), an extensively studied RBP, and identified a circRNA, circ-defective in cullin neddylation 1 domain containing 4 (circDCUN1D4), originating from the DCUN1D4 gene transcript. circDCUN1D4 is downregulated in tumor samples under the mediation of DExH-box helicase 9 (DHX9), which inhibits the formation of circRNA by binding inverted repeat Alus (IRAlus) in flanking sequences. circDCUN1D4 depletion promoted invasion in vitro and metastasis in vivo. Importantly, the interaction between circDCUN1D4 and HuR increased the transportation of HuR to the cytoplasm. circDCUN1D4 acts as a scaffold to facilitate the interaction between the HuR protein and thioredoxin-interacting protein (TXNIP) mRNA, which enhances the stability of the TXNIP mRNA. Additionally, circDCUN1D4 directly interacts with TXNIP mRNA through base complementation, indicating the formation of the circDCUN1D4/HuR/TXNIP RNA-protein ternary complex. Furthermore, circDCUN1D4 suppressed metastasis and glycolysis of lung cancer cells in a TXNIP-dependent manner. Clinically, the downregulated expression of circDCUN1D4 was more prevalent in lymph node metastatic tissues and served as an independent risk factor for the overall survival of lung adenocarcinoma (LUAD) patients. These findings demonstrated that a novel circRNA, circDCUN1D4, is involved in the metastasis and glycolysis of LUAD.
Found
Nothing found, try to update filter.
Found
Nothing found, try to update filter.
Top-30
Journals
|
1
2
3
4
|
|
|
Molecular Cancer
4 publications, 3.39%
|
|
|
Cancer Letters
4 publications, 3.39%
|
|
|
Thoracic Cancer
4 publications, 3.39%
|
|
|
Bioengineered
4 publications, 3.39%
|
|
|
Frontiers in Oncology
3 publications, 2.54%
|
|
|
Cell Death and Disease
3 publications, 2.54%
|
|
|
Journal of Experimental and Clinical Cancer Research
3 publications, 2.54%
|
|
|
Antioxidants and Redox Signaling
2 publications, 1.69%
|
|
|
Molecular Medicine Reports
2 publications, 1.69%
|
|
|
Cancers
2 publications, 1.69%
|
|
|
Molecular Medicine
2 publications, 1.69%
|
|
|
Oncogene
2 publications, 1.69%
|
|
|
Molecular and Cellular Biochemistry
2 publications, 1.69%
|
|
|
Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis
2 publications, 1.69%
|
|
|
Translational Oncology
2 publications, 1.69%
|
|
|
Life Sciences
2 publications, 1.69%
|
|
|
Cancer Communications
2 publications, 1.69%
|
|
|
Journal of Clinical Laboratory Analysis
2 publications, 1.69%
|
|
|
Cells
2 publications, 1.69%
|
|
|
Advances in Experimental Medicine and Biology
2 publications, 1.69%
|
|
|
Current Gene Therapy
1 publication, 0.85%
|
|
|
Biomolecules
1 publication, 0.85%
|
|
|
Frontiers in Immunology
1 publication, 0.85%
|
|
|
Vaccines
1 publication, 0.85%
|
|
|
Bone Research
1 publication, 0.85%
|
|
|
Journal of Hematology and Oncology
1 publication, 0.85%
|
|
|
Neurotoxicity Research
1 publication, 0.85%
|
|
|
Human Cell
1 publication, 0.85%
|
|
|
Molecular Therapy - Oncolytics
1 publication, 0.85%
|
|
|
1
2
3
4
|
Publishers
|
5
10
15
20
25
30
35
40
|
|
|
Springer Nature
36 publications, 30.51%
|
|
|
Elsevier
23 publications, 19.49%
|
|
|
Wiley
13 publications, 11.02%
|
|
|
Taylor & Francis
8 publications, 6.78%
|
|
|
MDPI
7 publications, 5.93%
|
|
|
Frontiers Media S.A.
6 publications, 5.08%
|
|
|
Spandidos Publications
4 publications, 3.39%
|
|
|
Mary Ann Liebert
3 publications, 2.54%
|
|
|
Oxford University Press
2 publications, 1.69%
|
|
|
Cold Spring Harbor Laboratory
2 publications, 1.69%
|
|
|
Bentham Science Publishers Ltd.
1 publication, 0.85%
|
|
|
Neoplasia Press
1 publication, 0.85%
|
|
|
Federation of American Societies for Experimental Biology (FASEB)
1 publication, 0.85%
|
|
|
Walter de Gruyter
1 publication, 0.85%
|
|
|
Hindawi Limited
1 publication, 0.85%
|
|
|
American Society for Microbiology
1 publication, 0.85%
|
|
|
SAGE
1 publication, 0.85%
|
|
|
S. Karger AG
1 publication, 0.85%
|
|
|
Public Library of Science (PLoS)
1 publication, 0.85%
|
|
|
AME Publishing Company
1 publication, 0.85%
|
|
|
5
10
15
20
25
30
35
40
|
- We do not take into account publications without a DOI.
- Statistics recalculated weekly.
Are you a researcher?
Create a profile to get free access to personal recommendations for colleagues and new articles.
Metrics
118
Total citations:
118
Citations from 2024:
38
(32.2%)
Cite this
GOST |
RIS |
BibTex
Cite this
GOST
Copy
Liang Y. et al. circDCUN1D4 suppresses tumor metastasis and glycolysis in lung adenocarcinoma by stabilizing TXNIP expression // Molecular Therapy - Nucleic Acids. 2021. Vol. 23. pp. 355-368.
GOST all authors (up to 50)
Copy
Liang Y., Wang H., Chen B., Qixing M., Xia W., Zhang T., Song X., ZHANG Ze-yu 张., Xu L., Dong G., Jiang F. circDCUN1D4 suppresses tumor metastasis and glycolysis in lung adenocarcinoma by stabilizing TXNIP expression // Molecular Therapy - Nucleic Acids. 2021. Vol. 23. pp. 355-368.
Cite this
RIS
Copy
TY - JOUR
DO - 10.1016/j.omtn.2020.11.012
UR - https://doi.org/10.1016/j.omtn.2020.11.012
TI - circDCUN1D4 suppresses tumor metastasis and glycolysis in lung adenocarcinoma by stabilizing TXNIP expression
T2 - Molecular Therapy - Nucleic Acids
AU - Liang, Yingkuan
AU - Wang, Hui
AU - Chen, Bing
AU - Qixing, Mao
AU - Xia, Wen-Jie
AU - Zhang, Te
AU - Song, XuMing
AU - ZHANG Ze-yu, 张泽宇
AU - Xu, Lin
AU - Dong, Gaochao
AU - Jiang, Feng
PY - 2021
DA - 2021/03/01
PB - Elsevier
SP - 355-368
VL - 23
PMID - 33425493
SN - 2162-2531
ER -
Cite this
BibTex (up to 50 authors)
Copy
@article{2021_Liang,
author = {Yingkuan Liang and Hui Wang and Bing Chen and Mao Qixing and Wen-Jie Xia and Te Zhang and XuMing Song and 张泽宇 ZHANG Ze-yu and Lin Xu and Gaochao Dong and Feng Jiang},
title = {circDCUN1D4 suppresses tumor metastasis and glycolysis in lung adenocarcinoma by stabilizing TXNIP expression},
journal = {Molecular Therapy - Nucleic Acids},
year = {2021},
volume = {23},
publisher = {Elsevier},
month = {mar},
url = {https://doi.org/10.1016/j.omtn.2020.11.012},
pages = {355--368},
doi = {10.1016/j.omtn.2020.11.012}
}